Arena, Eisai sales and marketing update

Arena disclosed in an SEC filing that partner Eisai set a wholesale acquisition cost of $199.50 for a one-month supply of twice-daily Belviq lorcaserin to treat obesity. Last June, FDA approved Belvi...